LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma

[1]  Jing Pan,et al.  LncRNA DGCR5 contributes to CSC‐like properties via modulating miR‐330‐5p/CD44 in NSCLC , 2018, Journal of cellular physiology.

[2]  Tingting Li,et al.  Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression. , 2018, Cancer letters.

[3]  W. Pang,et al.  Long noncoding RNA: multiple players in gene expression , 2018, BMB reports.

[4]  Mousheng Xu,et al.  YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis. , 2018, Cancer research.

[5]  Jing Zhang,et al.  LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. , 2018, The international journal of biochemistry & cell biology.

[6]  Gang Meng,et al.  Long non-coding RNA MUC5B-AS1 promotes metastasis through mutually regulating MUC5B expression in lung adenocarcinoma , 2018, Cell Death & Disease.

[7]  Jia-bao Liu,et al.  LncRNA DANCR Promotes Lung Cancer by Sequestering miR-216a , 2018, Cancer control : journal of the Moffitt Cancer Center.

[8]  Hai-bo Wu,et al.  Long non‐coding RNA SNHG15 promotes CDK14 expression via miR‐486 to accelerate non‐small cell lung cancer cells progression and metastasis , 2018, Journal of cellular physiology.

[9]  Guoyang Wu,et al.  lncRNA BANCR promotes EMT in PTC via the Raf/MEK/ERK signaling pathway. , 2018, Oncology letters.

[10]  Y. Sekido.  Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma , 2018, Cancers.

[11]  T. Mak,et al.  Loss of Mob1a/b in mice results in chondrodysplasia due to YAP1/TAZ-TEAD-dependent repression of SOX9 , 2018, Development.

[12]  S. Hong,et al.  Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival. , 2018, Pathology, research and practice.

[13]  Hue Lee,et al.  A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop , 2018, Theranostics.

[14]  Jia Liu,et al.  Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer. , 2018, Biochemical and biophysical research communications.

[15]  Q. Kong,et al.  Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. , 2018, Biochemical and biophysical research communications.

[16]  Y. Ye,et al.  LncRNA Gas5 acts as a ceRNA to regulate PTEN expression by sponging miR-222-3p in papillary thyroid carcinoma , 2017, Oncotarget.

[17]  W. Qu,et al.  LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway. , 2018, Cancer biomarkers : section A of Disease markers.

[18]  Q. Gao,et al.  MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma. , 2018, Cancer letters.

[19]  Rongkuan Hu,et al.  miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer. , 2018, Cancer letters.

[20]  E. K. Lee,et al.  MicroRNA-195 desensitizes HCT116 human colon cancer cells to 5-fluorouracil. , 2018, Cancer letters.

[21]  Youwei Zhu,et al.  MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes. , 2018, Cancer letters.

[22]  Wei Li,et al.  Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA. , 2017, Cancer letters.

[23]  I. Cavalli,et al.  Long Non-Coding RNA TUG1 Expression Is Associated with Different Subtypes in Human Breast Cancer , 2017, Non-coding RNA.

[24]  Bosheng Li,et al.  miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway. , 2017, Cancer letters.

[25]  S. Zhang,et al.  Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B , 2017, Molecular therapy. Nucleic acids.

[26]  Jingnan Shen,et al.  lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition. , 2017, Cancer letters.

[27]  Yan Zhou,et al.  Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3 , 2017, Oncotarget.

[28]  Y. Wang,et al.  Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells , 2017, Oncogene.

[29]  Guosong Jiang,et al.  LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2. , 2017, Cancer letters.

[30]  Muhammad Nawaz,et al.  Vesiculated Long Non-Coding RNAs: Offshore Packages Deciphering Trans-Regulation between Cells, Cancer Progression and Resistance to Therapies , 2017, Non-coding RNA.

[31]  Hongbing Shen,et al.  Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling , 2017, Oncogene.

[32]  Hu Zhao,et al.  [Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells]. , 2017, Zhonghua nan ke xue = National journal of andrology.

[33]  S. Zhang,et al.  Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B , 2017, Molecular therapy. Nucleic acids.

[34]  Fuman Qiu,et al.  Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma. , 2016, Cancer letters.

[35]  Y. Wang,et al.  Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis. , 2016, Cancer letters.

[36]  Liqing Zhou,et al.  Onco-lncRNA HOTAIR and its functional genetic variants in papillary thyroid carcinoma , 2016, Scientific Reports.

[37]  Zhang Jh,et al.  Long noncoding RNA SNHG15, a potential prognostic biomarker for hepatocellular carcinoma. , 2016 .

[38]  Z. Lu,et al.  Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b , 2015, Oncogene.

[39]  J-H Zhang,et al.  Long noncoding RNA SNHG15, a potential prognostic biomarker for hepatocellular carcinoma. , 2016, European review for medical and pharmacological sciences.

[40]  C. Xie,et al.  Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC , 2016, Tumor Biology.

[41]  Youxin Wang,et al.  Increasing Incidence of Thyroid Cancer in Shanghai, China, 1983-2007 , 2011, Asia-Pacific journal of public health.

[42]  U. Feldt-Rasmussen,et al.  Thyroid cancer in Denmark 1943–2008, before and after iodine supplementation , 2012, International journal of cancer.

[43]  D. Henson,et al.  Changing Patterns in the Incidence and Survival of Thyroid Cancer with Follicular Phenotype—Papillary, Follicular, and Anaplastic: A Morphological and Epidemiological Study , 2007, Endocrine pathology.

[44]  E. Mazzaferri,et al.  Increasing Incidence of Thyroid Cancer in the United States, 1973–2002Davies L, Welch HG (Dept of Veterans Affairs Med Ctr, White River Junction, Vt; Darmouth Med School, Hanover, NH) JAMA 295:2164–2167, 2006§ , 2007 .

[45]  O. Gimm.  Thyroid cancer. , 2001, Cancer letters.

[46]  I. Fleming,et al.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.

[47]  P DESAIVE,et al.  [Thyroid cancer]. , 1951, Revue medicale de Liege.